O Dr. Yildiz publicou extensivamente sobre casos raros de cancro, incluindo tumores neuroendócrinos e síndromes paraneoplásicas, no Hospital Universitário Medipol Mega.

• Especializar-se no diagnóstico e tratamento de casos complexos de cancro de bexiga
• Escrever múltiplos estudos sobre apresentações de tumores raros
• Gerir complicações endócrinas relacionadas com o cancro
• Focar-se em abordagens de tratamento personalizadas

Dra. Turkan Ozturk Topcu é especialista no tratamento do cancro da bexiga, com formação extensiva nos principais centros oncológicos de todo o mundo.

• Especialista em oncologia médica com mais de 18 anos de experiência
• Formada no MD Anderson Cancer Center e no Moffitt Cancer Center
• Trabalhou anteriormente na clínica de oncologia médica da Universidade Técnica de Karadeniz
• Especialista no tratamento de vários cancros urológicos, incluindo o cancro da bexiga

O Dr. Kaplan é especializado em放射onco-radiologia para cancro da bexiga no Hospital Universitário Medipol Mega.

• Focar-se em técnicas de radioterapia de precisão
• Trabalhar num hospital universitário de referência
• Dedicar-se a planos de tratamento personalizados

O Professor Associado Tahsin Ozatli é especialista em cancros da mama, do pulmão e gastrointestinais, tratando doentes no Hospital Liv da Universidade Istinye, em Bahcesehir.

• Formar-se em medicina interna no Hospital Estatal de Malatya
• Trabalhar na Clínica de Oncologia de Ancara com foco em oncologia
• Membro do departamento de oncologia do Hospital Regional de Formação e Investigação de Erzurum
• Professor associado desde 2016

O Professor Cemil Bilir é especializado em cancro da bexiga, com formação extensiva em instituições de prestígio como a Cleveland Clinic e a Northeastern University.

• Certificado em oncologia médica com mais de 15 anos de experiência
• Membro da ASCO e ESMO – seguir as diretrizes internacionais de tratamento
• Realizar investigação em biotecnologia farmacêutica para terapias avançadas
• Professor na Universidade de Sakarya – formar futuros oncologistas

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

O Prof. Adjunto Nail Paksoy é especialista no tratamento do cancro da bexiga no Hospital Medipol Bahçelievler, contando com uma vasta experiência em investigação e ensaios clínicos.

• Certificado pelo Conselho da ESMO em Oncologia Médica
• Participação em múltiplos ensaios clínicos internacionais para o carcinoma urotelial
• Investigação publicada sobre fatores de prognóstico no cancro da bexiga metastático
• Formação de especialização (Fellowship) no Instituto de Oncologia da Universidade de Istambul

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

O Dr. Ozden é especialista no tratamento do cancro da bexiga com formação extensiva em oncologia médica na Faculdade de Medicina da Universidade de Kocaeli.

• Mais de 20 anos de experiência em medicina interna e oncologia
• Formado na Universidade de Istambul, uma das melhores faculdades de medicina da Turquia
• Especialista em protocolos de quimioterapia e imunoterapia para o cancro da bexiga

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

O Dr. Yurdakul é especializado em uro-oncologia com formação avançada pela Cleveland Clinic Ohio e University of Pittsburgh, focando em tratamentos de cancro da bexiga.

• Mais de 17 anos de experiência em urologia e uro-oncologia
• Publicação de 16 artigos científicos internacionais e 58 nacionais
• Formação em cirurgia microvascular na Mercy University
• Palestrante e presidente de sessão em reuniões nacionais de urologia

A Profa. Associada Serap Kaya traz sua especialização oncológica de hospitais acadêmicos para o Hospital Emsey.

• Especialização em Oncologia Médica na Universidade de Kocaeli
• Prática no Hospital de Treinamento e Pesquisa Kartal Dr. Lütfi Kırdar
• Membro atual do corpo docente do Hospital Emsey
• Experiência em oncologia adulta e pediátrica

Field of Speciality: Urology
Date of Birth: 1980
School of Medicine:  Istanbul University School of Medicine
Graduate Medical Education: University of Health Sciences Taksim Training & Research Hospital
Fellowship: Urological Oncology and Laparoscopic Urology Department of Urology SLK Kliniken Heilbronn University of Heidelberg, Germany
Foreign Language: English

Having graduated from Istanbul University, Faculty of Medicine in Istanbul, he pursued Urological Surgery residency at University of Health Sciences Taksim Training & Research Hospital, Istanbul from 2005 to 2010. He subsequently completed fellowship training in Urological Oncology and Laparoscopic Urology at Department of Urology, Heilbronn, Heidelberg University, Germany.Dr. Taş is able to provide patients curative surgery that is extremely precise, preserves sexual function, has minimal blood loss, minimal pain and quick recovery.

Firsts of Safe Urology Clinic in Turkey: Penis injections of:
Cellular derived from adipose tissue
Autologous bone marrow mesenchymal Cellular
Male-Shot

​

After graduating from Istanbul Medical Faculty in 2004, Dr. Tuncay Taş completed his specialization in Urology at Taksim Training and Research Hospital in 2010. After the training he received in 2006 and 2007 at the “Laparoscopy, Robotics and Oncology Center” of Heildelberg University, Heilbronn SLK Hospital, Germany, he continues to serve his patients in Turkey, especially in the field of Laparoscopic/Robotic Surgery. The majority of Tuncay Taş’s urology practice consists of man sexual health, cancer diagnosis and treatments

His sexual health and wellness practice offers cutting-edge technologies and treatment options for men. Dr Tas offers unique training and clinical protocols for practitioners who want to implement   Penile Implants , Penile Enhancement , SafeFill and MaleShot  into their practice. Dr Taş and his team presented the results of combined P.R.P (MALE-P-SHOT) and SVF application to the penis for the first time in Turkey at the scientific congress and shared the clinical results of these applications. It is also one of the first 5 centers in the world to publish the results of P.R.P (P.SHOT) applications. Dr Taş is one of the urology instructors at ISSCA who is fully involved in regenerative medicine.

(Source: At the congress organized by İHA International Cellular Therapies Association, Dr. Tuncay Taş shared his cell research in clinical regenerative medicine and erectile dysfunction. 2019, Sexual Medicine-Original Research2021, Apr;9(2):100313.doi:10.1016/j.esxm.2020.100313. Epub 2021 30 January.)

​

Recently Dr. Tas has developed a safe and effective treatment to improve penile circumference and has conducted training with a UK-based certification programme. This novel technique has been shown to have impressive and durable cosmetic results.

​

​

OTHER AREAS OF FOCUS

Robotic prostatectomy, Radical prostatectomy, HoLEP, Donor nephrectomy, Nephrectomy, Robotic surgery, Laparoscopic surgery, Prostate cancer, Kidney cancer, Bladder cancer, Testicular cancer, Retroperitoneal lymph node dissection for testicular cancer, Erectile dysfunction, Sexual dysfunction, Male infertility, Varicocelectomy, Male hypogonadism, Penile implant insertion, Urethroplasty, Penile reconstruction, Penile enlargement, Urethral reconstruction, Artificial urinary sphincter implantation, Bladder botox injection, Urodynamic testing, Bladder augmentation, Urinary diversion, Urethral stricture, Ureteral obstruction, HIPEC, Reconstructive surgery, Laparoscopic surgery, Fertility preservation, Minimally invasive surgery, Hypospadias

​

Membership of Scientific Organizations

Turkish Association of Urology
Turkish Medical Association
Association of Endourology
European Association of Urology
International Society for Stem Cells Applications

• Publications
https://scholar.google.com/citations?user=CA59D8UAAAAJ&hl=en

​

O Dr. Tanriverdi é especialista em tratamentos de cancro da bexiga, com foco em técnicas minimamente invasivas e assistidas por robótica.

• 23 anos de experiência em oncologia cirúrgica e urologia
• Especialista em cirurgia urológica laparoscópica assistida por robô
• Membro da Associação Europeia de Urologia e da Associação Americana de Urologia
• 31 publicações internacionais sobre cirurgias urológicas

Especializado em radioncologia pela Universidade de Marmara, o Dr. Sahibov foca-se no tratamento do cancro da bexiga no Hospital Emsey.

• Ter concluído uma formação rigorosa na Faculdade de Medicina da Universidade de Marmara
• Especializar-se em radioncologia com foco no cancro da bexiga
• Trabalhar no Hospital Emsey, um centro de referência em cuidados oncológicos

A Prof.ª Dr.ª Senem Karabulut é especialista em cancros geniturinários, incluindo o cancro da bexiga, com vasta experiência em imunoterapias e tratamentos direcionados.

• Título de especialista em Oncologia Médica com qualificação ESMO
• Doutoramento em Oncologia Molecular – foco em tratamentos avançados
• Professora na Universidade de Istambul – formação de futuros oncologistas
• Premiada pela excelência na investigação em oncologia

O Dr. Topcu é especialista em cancro da bexiga, com formação internacional no MD Anderson Cancer Center e no Sunnybrook Odette Cancer Center em cancro da mama.

• Mais de 15 anos de experiência em oncologia médica
• Membro da European Society for Medical Oncology (ESMO) e da American Society of Clinical Oncology (ASCO)
• Trabalhar no Hospital Universitário Biruni com abordagens de tratamento avançadas